Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring

This is a prospective, monocentric diagnostic study aiming to evaluate whether a sedation score obtained by a per-procedural electroencephalogram (EEG), the PSI score, could identify patients for whom a 2 μg/kg dose of DEX would not be sufficient for the successful performance of cerebral NMRI, and who could therefore benefit from a higher dosage of DEX (4 μg/kg).

NCT Number	NCT06867289
Lead Sponsor	Centre Hospitalier Régional Metz-Thionville
Conditions	Procedural Sedation and Analgesia, Pediatric ALL
Enrollment	50 participants
Start Date	2025-04-08
Primary Completion	2027-04-08 (estimated)
Study Completion	2027-04-08 (estimated)
Updated on ClinicalTrials.gov	2026-03-12